Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  236,357 results for ""Immunotherapy""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Immunotherapy.
Research Starter

Immunotherapy.

  • Cancers treated: Breast cancer, lung cancer, melanoma, cervical cancer, leukemias, lymphomas, myelomas, prostate cancer, colorectal cancer, and ovarian cancer; others ... More
  • Salem Press Encyclopedia of Health, 2022. 3p.
Academic Journal

Immunotherapy of Hematological Malignancies of Human B-Cell Origin with CD19 CAR T Lymphocytes.

  • Authors : Khvorost D; Department of Life Sciences, Los Angeles City College (LACC), 855 N. Vermont Ave., Los Angeles, CA 90029, USA.; Kendall B

Subjects: Antigens, CD19*/Antigens, CD19*/Antigens, CD19*/immunology ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/immunology

  • Source: Cells [Cells] 2024 Apr 09; Vol. 13 (8). Date of Electronic Publication: 2024 Apr 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Read Online Read More Add to Saved list
×
Academic Journal

CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours.

  • Authors : Tang HKC; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.; Wang B

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology; Humans

  • Source: Cells [Cells] 2023 Jun 08; Vol. 12 (12). Date of Electronic Publication: 2023 Jun 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.

  • Authors : Rivera Z; Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, IL 60612, USA.; Escutia C

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 May 09; Vol. 24 (10). Date of Electronic Publication: 2023 May 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.

  • Authors : Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. .; Brentjens R

Subjects: Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/therapy; Humans

  • Source: Journal of translational medicine [J Transl Med] 2023 Apr 22; Vol. 21 (1), pp. 275. Date of Electronic Publication: 2023 Apr 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Tumor therapeutic response monitored by telemetric temperature sensing, a preclinical study on immunotherapy and chemotherapy.

  • Authors : Shao Q; Department of Mechanical Engineering, University of Minnesota, Minneapolis, USA. .; Lundgren M

Subjects: Immunotherapy* ; Melanoma*/Melanoma*/Melanoma*/pathology; Animals

  • Source: Scientific reports [Sci Rep] 2023 May 12; Vol. 13 (1), pp. 7727. Date of Electronic Publication: 2023 May 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies.

  • Authors : Huang S; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Receptors, Antigen, T-Cell*/Receptors, Antigen, T-Cell*/Receptors, Antigen, T-Cell*/genetics; Humans

  • Source: Molecular cancer [Mol Cancer] 2023 May 06; Vol. 22 (1), pp. 80. Date of Electronic Publication: 2023 May 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer.

  • Authors : Wang M; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, 250117, Shandong Province, China.; Jing X

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/immunology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/mortality

  • Source: BMC cancer [BMC Cancer] 2024 May 07; Vol. 24 (1), pp. 569. Date of Electronic Publication: 2024 May 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.

  • Authors : Qu J; Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, P. R. China.; The Clinical Research Center for Respiratory Diseases of Zhejiang Province, Hangzhou, Zhejiang, 310003, P. R. China.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/immunology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 May 03; Vol. 43 (1), pp. 134. Date of Electronic Publication: 2024 May 03.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.

  • Authors : Sukocheva OA; Department of Hepatology, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia. .; Neganova ME

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

  • Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 May 02; Vol. 22 (1), pp. 251. Date of Electronic Publication: 2024 May 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The potential and promise for clinical application of adoptive T cell therapy in cancer.

  • Authors : Li Y; Department of Pharmacy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, China.; Zheng Y

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods

  • Source: Journal of translational medicine [J Transl Med] 2024 May 01; Vol. 22 (1), pp. 413. Date of Electronic Publication: 2024 May 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  236,357 results for ""Immunotherapy""